new glp-1 drug Guidelines for Type 2 Diabetes in 2025 GLP-1 Drugs Cut Risk of
Description
Sten Madsbad, Institute of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
2018;3:e000219
Fura A., Khanna A., Vyas V., et al., Pharmacokinetics of the Dipeptidyl Peptidase 4 Inhibitor Saxagliptin in Rats, Dogs, and Monkeys and Clinical Projections, Drug Metabolism and Disposition 37, no
Christensen M, Sparre-Ulrich AH, Hartmann B, Grevstad U, Rosenkilde MM, Holst JJ, et al
ESC heart failure
11, 18 Mar
